Company research
Conexeu Sciences Inc.
CIK 2066836Updated Sep 24, 2026
SecurityCNXU · NASDAQ · equity
CNXU price & chart
Loading TradingView…
NASDAQ:CNXU on TradingView ↗About the company
The Company's proprietary formula, CXUTM, is an ECM scaffold device candidate protected by patents (collectively, the "Patents") in Australia, and the European Union (validated in Belgium, Switzerland, Germany, Spain, France, Great Britain, Ireland, Italy, and the Netherlands), Japan, and the USA, which form a critical barrier to entry and secure our competitive advantage in regenerative medicine. Origin and ownership of the Company's core patent rights were assigned from the University. Patent protection in Canada for such proprietary ECM scaffold technology remains pending. The Patents are summarized in the table below:
In the news
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One ↗
Recent filings
Show 5 more recent filings
Offerings
Registration 333-291845
- Offering price
- market-price
- Ticker
- CNXU